Effect of selenium-enriched malt on VEGF and several relevant angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 1, 2010, Pages 52-57

  Liu, Jia Guo ^a   Zhao, Hong Jin ^a   Liu, Yan Juan ^a   Wang, Xiao Long ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Angiogenesis; IGF II; Selenium enriched malt; TNF ; VEGF

Indexed keywords

CYTOKINE; DIETHYLNITROSAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SELENIUM; SOMATOMEDIN B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MALT; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT;

ANIMALS; CEREALS; CYTOKINES; DIETHYLNITROSAMINE; LIVER NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 73449102474     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2009.10.001     Document Type: Article

References (54)

1. Liu Q., and Wang W.Q. Hepatocarcinoma (2000), The People's Health Press, Beijing
2. Wang S.S., Zheng Z.G., Weng Y.Q., Yu Y.J., Zhang D.F., Fan W.H., Dai R.H., and Hu Z.B. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 74 (2004) 2467-2478
3. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
4. Folkman J., and Klagsbrun M. Angiogenetic factors. Science 235 (1987) 442-447
5. Reher P., Doan N., Bradnock B., Meghjia S., and Harris M. Effect of ultrasound on the production of IL-8, basic FGF and VEGF. Cytokine 11 (1999) 416-423
6. Thomas K.A. Vascular endothelial growth factor: a potent and selective angiogenic agent. Journal of Biological Chemistry 271 (1996) 603-606
7. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor a critical cytokine in tumor angiogenesis and potential target for diagnosis and therapy. Joural of Clinical Oncology 20 (2002) 4368-4380
8. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability,and angiogenesis. The Journal of Clinical Investigation 146 (1995) 1029-1039
9. Lü J.X., and Cheng J. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Nutrition and Cancer 40 1 (2001) 64-73
10. Babei S., Teichert-Kuliszewska K., Zhang Q., Jones N., Dumont D.J., and Stewart D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. The American Journal of Pathology 162 (2003) 1927-1936
11. Papapetropoulos A., Garcia-Cardena G., Madri J.A., and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. The Journal of Clinical Investigation 100 (1997) 3131
12. Yang D.Y., and Rogler C.E. Analysis of insulin-like growth factor II expression in neoplastic nodules and hepatocellular carcinomas of the woodchuck utilizing in situ hybridization and immunohistochemistry. Carcinogenesis 12 (1991) 1893-1901
13. Park B.C., Huh M.H., and Seo J.H. Differential expression of transforming growth factor α and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. Journal of Hepatology 22 (1995) 286-294
14. Bae M.H., Lee M.J., Bae S.K., Lee O.H., Lee Y.M., Park B.C., and Kim K.W. Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Letters 12 (1998) 41-46
15. Berse B., Hunt J.A., Diegel R.J., Morganell P., Yeo K.T., and Brown F. Hypoxia augments cytokine [transforming growth factor-beta(TGF-β) and IL-1]-induced vascular endothelial growth factor secretion by human synovial fihrohlasts. Clinical and Experimental Immunology 115 (1999) 176-182
16. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., and El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1(CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis & Rheumatism 46 (2002) 2587-2597
17. Jackson J.R., Minton J.A., Ho M.L., Wei N., and Winkler J.D. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin-1 beta. The Journal of Rheumatology 24 (1997) 1253-1259
18. Combs Jr. G.F., Clark L.C., and Turnbull B.W. An analysis of cancer prevention by selenium. Biofactors 14 (2001) 153-159
19. Raich P.C., Lü J.X., Thompson H.J., and Combs Jr. G.F. Selenium in cancer prevention: clinical issues and implications. Cancer Investigation 19 5 (2001) 540-553
20. Mc Carty M.F. The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. Medical Hypotheses 64 (2005) 159-161
21. Jing J.X., Han C.Z., and Zheng S.M. Study on correlation of serum, tumor tissue selenium and SIL-2R, TNF-α. Chinese Journal of Clinical Oncology 27 (2000) 565-567
22. Li X., Liu Y.M., Qi Z.M., Meng J.R., Liu S.X., and Li J.X. Effect of Se on Levels of IL-2, IL-6 and TNF-α in murine serum. China Animal Husbandry & Veterinary Medicine 34 (2007) 99-101
23. Zhang H.L., Jiang Y.F., Fu Z.D., and Chen W.R. Effect of Se-PSK on NO content in macrophages. Chinese Traditional and Herbal Drugs 32 (2001) 820-822
24. Deng Y., Huang K.X., and Xu H.B. Study of the inhibition of selenium on NO-induced cell injury in human umbilical vein endothelial cells and its mechanism. Journal of Huazhong University of Science and Technology 30 (2002) 101-104
25. Bird S.M., Ge H., Uden P.C., Tyson J.F., Block E., and Denoyer E. High-performance liquid chromatography of selenoamino acids and organo selenium compounds: speciation by inductively coupled plasma mass spectrometry. Journal of Chromatography A 789 (1997) 349-359
26. Popova N.V. Perinatal selenium exposure decreases spontaneous liver tumorogenesis in CBA mice. Cancer Letter 179 1 (2002) 39-42
27. Xu Z.L., Guo J.H., Li M.J., Liang Y.Q., and Wei S.J. The protective action of malt-Se to cardiotoxicity of doxorubicin by malt-Se. Journal of China Modern Application Medicine 17 (2000) 269-272
28. Li J.K., and Wang X.L. Effect of dietary organic versus inorganic selenium in laying hens on the productivity, selenium distribution in egg and selenium content in blood, liver and kidney. Journal of Trace Elements in Medicine and Biology 18 (2004) 65-68
29. Liu J.G., Zhao S., Liu H.J., and Wang X.L. Effect of selenium-enriched malt on the antioxidative function and γ-GTase activity in the course of acute hepatocarcinogenesis induced by AFB1 in rats. Journal of Nanjing Agricultural University 28 1 (2005) 85-89
30. Liu J.G., Zhao H.J., Liu Y.J., and Wang X.L. Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine. Life Sciences 78 20 (2006) 2315-2321
31. Zhu H. The research of production selenium malt. Journal of Mountain Agricultural Biology 4 (1999) 24-27
32. Xu R., and Xiao P. The study on the form of selenium in Se-malt. Science Food Index 4 (1989) 7-9
33. Palmer R.M.J., and Moncad S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factors. Nature 327 (1987) 524-526
34. Brereton R.G. SAS (Statistical Analysis System). Chemometrics and Intelligent Laboratory Systems 1 1 (1986) 9
35. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., Siegel N.R., Leimgruber R.M., and Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. The Journal of Clinical Investigation 84 (1989) 1470-1478
36. Senger D., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., and Dvorak H.F. Tumor cells secrete a vascular permeability factor which promotesascites fluid accumulation. Science 219 (1983) 983-985
37. Sun D., Matsune S., Ohori J.C., Fukuiwa T., Ushikai M., and Kurono. Y.C. TNF-α and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 32 (2005) 243-249
38. Sauter E.R., Nosbit M., Watson J.C., Klein-Szanto A., Litwin S., and Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research 5 (1999) 775-782
39. Zhao H.J. Effect and mechanism of selenium-enriched malt on hepatocarcinogenesis induced by diethylinitrosamine in rats (2005), College of Veterinary Medicine, Nanjing Agricultural University, China pp. 93-110
40. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase /cGMP-dependent pathway. The American Journal of Physiology 276 (1999) C1148-C1153
41. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
42. Scalia R., Booth G., and Lefer D.J. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. The Journal of FASEB 9 (1999) 1039-1046
43. Jozkowicz A., Cooke J.P., Guevara I., Huk I., Funovics P., Pachinger O., Weidinger F., and Dulac J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovascular Research 51 (2001) 773-783
44. Hood J.D., Meininger C.J., Ziche M., and Granger. H.J. VEGF upregulates ecNOS message, protein and NO production in human endothelial cells. The American Journal of Physiology 273 (1998) H1054-H1058
45. Gallo O., Schiavone N., Papucci L., Sardi I., Magnelli L., and Franchi A. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. The Journal of Clinicical Investigation 163 (2003) 723
46. Sakuta T., Matsushita K., and Yamaguchi N. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxins through transcription factor SP-1. Journal of Medical Microbiology 50 (2001) 233-237
47. Christofori G., Naik P., and Hanahan. D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 (1994) 414-418
48. Lamm G.M., and Christofori G. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Cancer Research 58 (1998) 801-807
49. Xu F., Gardner T.Y.A., Michl P., Prager D., and Lichtenstein A. Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors. British Journal of Haematology 97 (1997) 429-440
50. Mooney A., Jobson T., Bacon R., Kitamura M., and Savill J. Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis. The Journal of Immunology 159 (1997) 3949-3959
51. Coste A., Brugel L., Maitre B., Boussat S., Papon J.F., and Wingerstmann L. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. European Respiratory Journal 15 (2000) 367-372
52. Peron J.M., Shurin M.R., and Lotze M.T. Cytokine gene therapy of cancer. In: Lattime E.C., and Gerson S.L. (Eds). Gene Therapy of Cancer (1999), Academic Press, San Diego, CA, USA
53. Colombo M.P., Modesti A., Parmiani G., and Forni G. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Research 15 (1992) 4853-4857
54. Rotruck J.T., Pope A.L., and Ganther H.E. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590